Clive Brown
Chief Tech/Sci/R&D Officer at OXFORD NANOPORE TECHNOLOGIES PLC
Net worth: 3 M $ as of 30/03/2024
Profile
Clive G. Brown occupies the position of Chief Technology Officer & Director at Oxford Nanopore Technologies Plc. In the past Mr. Brown occupied the position of Director-Information Technology at Solexa Ltd., Principal at Oxford GlycoSciences Plc, Consultant at Wellcome Trust Sanger Institute and Consultant at Glaxo Wellcome, Inc. Clive G. Brown received an undergraduate degree from The University of York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/01/2024 | 1,720,213 ( 0.20% ) | 3 M $ | 30/03/2024 |
Clive Brown active positions
| Companies | Position | Start |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Chief Tech/Sci/R&D Officer | 30/06/2008 |
Former positions of Clive Brown
| Companies | Position | End |
|---|---|---|
| The SCO Group Ltd. | Director/Board Member | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Corporate Officer/Principal | - |
Solexa Ltd.
 Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Chief Tech/Sci/R&D Officer | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Training of Clive Brown
| The University of York | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Private companies | 5 |
|---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Solexa Ltd.
Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| The SCO Group Ltd. |
- Stock Market
- Insiders
- Clive Brown
